| Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ... New England Journal of Medicine 379 (11), 1007-1016, 2018 | 2287 | 2018 |
| Nonbiopsy diagnosis of cardiac transthyretin amyloidosis JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ... Circulation 133 (24), 2404-2412, 2016 | 1862 | 2016 |
| Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European heart journal 42 (16), 1554-1568, 2021 | 826 | 2021 |
| Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart … AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ... European journal of heart failure 15 (10), 1173-1184, 2013 | 813 | 2013 |
| A new staging system for cardiac transthyretin amyloidosis JD Gillmore, T Damy, M Fontana, M Hutchinson, HJ Lachmann, ... European heart journal 39 (30), 2799-2806, 2018 | 621 | 2018 |
| Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis MS Maurer, S Bokhari, T Damy, S Dorbala, BM Drachman, M Fontana, ... Circulation: Heart Failure 12 (9), e006075, 2019 | 494 | 2019 |
| Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) MS Maurer, M Hanna, M Grogan, A Dispenzieri, R Witteles, B Drachman, ... Journal of the American College of Cardiology 68 (2), 161-172, 2016 | 479 | 2016 |
| Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ... Circulation 139 (4), 431-443, 2019 | 456 | 2019 |
| Screening for transthyretin amyloid cardiomyopathy in everyday practice RM Witteles, S Bokhari, T Damy, PM Elliott, RH Falk, NM Fine, ... JACC: Heart Failure 7 (8), 709-716, 2019 | 321 | 2019 |
| Increased neuronal nitric oxide synthase-derived NO production in the failing human heart T Damy, P Ratajczak, AM Shah, E Camors, I Marty, G Hasenfuss, ... The Lancet 363 (9418), 1365-1367, 2004 | 321 | 2004 |
| Cardiac amyloidosis: updates in diagnosis and management D Mohty, T Damy, P Cosnay, N Echahidi, D Casset-Senon, P Virot, ... Archives of cardiovascular diseases 106 (10), 528-540, 2013 | 295 | 2013 |
| Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases P Garcia‐Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European journal of heart failure 23 (4), 512-526, 2021 | 289 | 2021 |
| Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week J Ternacle, L Krapf, D Mohty, J Magne, A Nguyen, A Galat, R Gallet, ... Journal of the American College of Cardiology 74 (21), 2638-2651, 2019 | 278 | 2019 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 265 | 2019 |
| Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness T Damy, B Costes, AA Hagège, E Donal, JC Eicher, M Slama, A Guellich, ... European heart journal 37 (23), 1826-1834, 2016 | 247 | 2016 |
| Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years B Iung, X Armoiry, A Vahanian, F Boutitie, N Mewton, JN Trochu, ... European journal of heart failure 21 (12), 1619-1627, 2019 | 235 | 2019 |
| Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure T Damy, KM Goode, A Kallvikbacka-Bennett, C Lewinter, J Hobkirk, ... European heart journal 31 (18), 2280-2290, 2010 | 217 | 2010 |
| Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis J Ternacle, D Bodez, A Guellich, E Audureau, S Rappeneau, P Lim, ... JACC: Cardiovascular Imaging 9 (2), 126-138, 2016 | 216 | 2016 |
| Current aspects of the spectrum of acute heart failure syndromes in a real‐life setting: the OFICA study D Logeart, R Isnard, M Resche‐Rigon, MF Seronde, P de Groote, ... European journal of heart failure 15 (4), 465-476, 2013 | 212 | 2013 |
| High prevalence of iron deficiency in patients with acute decompensated heart failure A Cohen‐Solal, T Damy, M Terbah, S Kerebel, JP Baguet, O Hanon, ... European journal of heart failure 16 (9), 984-991, 2014 | 197 | 2014 |
